4 completed, 3 terminated. 5 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Emergent Product Development Seattle LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis SBI-087, Placebo - Active Rheumatoid Arthritis | Phase 2 | Completed | Pfizer | 210 | 2009-12-01 | 2013-12-03 |
| Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus SBI-087 - Lupus Erythematosus, Systemic | Phase 1 | Completed | Pfizer | 30 | 2009-03-01 | 2018-12-07 |
| Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis SBI-087 - Arthritis, Rheumatoid | Phase 1 | Completed | Pfizer | 20 | 2008-12-01 | 2024-08-14 |
| Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis SBI-087 - Rheumatoid Arthritis | Phase 1 | Completed | Pfizer | 60 | 2008-03-31 | 2023-09-13 |
| Study Evaluating TRU-015 in B-Cell Non-Hodgkin's Lymphoma TRU-015 - Lymphoma, B-Cell | Phase 1 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 120 | 2007-09-01 | 2021-02-18 |
| Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus TRU-015 - Systemic Lupus Erythematosus | Phase 1 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 20 | 2007-08-01 | 2008-05-08 |
| Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome HuMax-CD4 (zanolimumab) - Mycosis Fungoides, Sezary Syndrome | Phase 3 | Terminated | Emergent Product Development Seattle LLC | 76 | 2005-07-01 | 2012-07-26 |
Arthritis, Rheumatoid (3) · Lupus Erythematosus, Systemic (2) · Glomerulonephritis, Membranous (1) · Lymphoma, B-Cell (1) · Lymphoma, T-Cell, Cutaneous (1) · Mycosis Fungoides (1) · Sezary Syndrome (1)
SBI-087 (4) · TRU-015 protein (2) · zanolimumab (1)
United States (6) · Canada (2) · Japan (2) · Spain (2) · Argentina (1) · Chile (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Mexico (1) · Poland (1) · Serbia (1)